Jeanette Pullen

6.3k total citations
82 papers, 3.2k citations indexed

About

Jeanette Pullen is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Jeanette Pullen has authored 82 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Public Health, Environmental and Occupational Health, 37 papers in Pediatrics, Perinatology and Child Health and 30 papers in Hematology. Recurrent topics in Jeanette Pullen's work include Acute Lymphoblastic Leukemia research (64 papers), Childhood Cancer Survivors' Quality of Life (35 papers) and Acute Myeloid Leukemia Research (20 papers). Jeanette Pullen is often cited by papers focused on Acute Lymphoblastic Leukemia research (64 papers), Childhood Cancer Survivors' Quality of Life (35 papers) and Acute Myeloid Leukemia Research (20 papers). Jeanette Pullen collaborates with scholars based in United States, Canada and Switzerland. Jeanette Pullen's co-authors include Bruce M. Camitta, Jonathan J. Shuster, Meenakshi Devidas, Michael J. Borowitz, Jan van Eys, Andrew J. Carroll, Alice L. Yu, JJ Shuster, W M Crist and S B Murphy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Jeanette Pullen

82 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeanette Pullen United States	34	2.1k	1.3k	1.3k	560	503	82	3.2k
Minnie Abromowitch United States	33	1.8k 0.8×	784 0.6×	1.1k 0.9×	454 0.8×	584 1.2×	67	3.0k
W. Paul Bowman United States	26	1.3k 0.6×	618 0.5×	915 0.7×	348 0.6×	336 0.7×	50	2.1k
Deepa Bhojwani United States	31	2.2k 1.0×	1.2k 0.9×	1.1k 0.9×	731 1.3×	957 1.9×	111	3.5k
Elisabeth R. van Wering Netherlands	40	3.1k 1.5×	1.3k 1.0×	2.4k 1.8×	1.4k 2.4×	653 1.3×	101	4.6k
William B. Slayton United States	23	715 0.3×	437 0.3×	941 0.7×	455 0.8×	474 0.9×	83	2.1k
C. Michel Zwaan Netherlands	38	1.3k 0.6×	647 0.5×	2.1k 1.6×	1.7k 3.0×	608 1.2×	152	3.9k
Jos P.M. Bökkerink Netherlands	21	645 0.3×	451 0.3×	218 0.2×	450 0.8×	295 0.6×	42	1.6k
Terry A. Vik United States	24	473 0.2×	558 0.4×	379 0.3×	795 1.4×	439 0.9×	79	2.1k
Elizabeth A. Raetz United States	48	5.4k 2.5×	3.0k 2.3×	2.9k 2.2×	1.6k 2.9×	2.2k 4.3×	245	7.7k
Wanda L. Salzer United States	22	1.2k 0.6×	885 0.7×	434 0.3×	221 0.4×	305 0.6×	54	1.8k

Countries citing papers authored by Jeanette Pullen

Since Specialization

Citations

This map shows the geographic impact of Jeanette Pullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanette Pullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanette Pullen more than expected).

Fields of papers citing papers by Jeanette Pullen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanette Pullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanette Pullen. The network helps show where Jeanette Pullen may publish in the future.

Co-authorship network of co-authors of Jeanette Pullen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanette Pullen. A scholar is included among the top collaborators of Jeanette Pullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanette Pullen. Jeanette Pullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asselin, Barbara L., Meenakshi Devidas, Lu Chen, et al.. (2015). Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404. Journal of Clinical Oncology. 34(8). 854–862. 145 indexed citations

Jones, Tamekia L., Bruce M. Camitta, Barbara L. Asselin, et al.. (2014). Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 36(5). 353–361. 7 indexed citations

Pullen, Jeanette, et al.. (2010). The effect of pilot balloon design on estimation of safe tracheal tube cuff pressure. Anaesthesia. 65(8). 785–791. 12 indexed citations

Rubnitz, Jeffrey E., David Wichlan, Meenakshi Devidas, et al.. (2008). Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. Journal of Clinical Oncology. 26(13). 2186–2191. 53 indexed citations

Chauvenet, Allen R., Paul L. Martin, Meenakshi Devidas, et al.. (2007). Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood. 110(4). 1105–1111. 40 indexed citations

Winick, Naomi, Paul L. Martin, Meenakshi Devidas, et al.. (2007). Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).. Blood. 110(11). 583–583. 6 indexed citations

Sutcliffe, Maxine J., Jonathan J. Shuster, Harland N. Sather, et al.. (2005). High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia. 19(5). 734–740. 88 indexed citations

Link, MP, et al.. (2002). Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia. 16(6). 1121–1126. 10 indexed citations

Shao, Li‐En, Mitchell B. Diccianni, Tetsuya S. Tanaka, et al.. (2001). Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication.. Cancer Research. 61(19). 7333–8. 53 indexed citations

10.

Shuster, JJ, et al.. (2000). Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia. 14(12). 2276–2285. 70 indexed citations

11.

Lauer, Stephen J., Bruce M. Camitta, Brigid G. Leventhal, et al.. (1998). Intensive Alternating Drug Pairs After Remission Induction for Treatment of Infants With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 20(3). 229–233. 25 indexed citations

12.

Alvarado, Carlos S., Garth E. Austin, Michael J. Borowitz, et al.. (1998). Myeloperoxidase Gene Expression in Infant Leukemia: A Pediatric Oncology Group Study. Leukemia & lymphoma. 29(1-2). 145–160. 8 indexed citations

13.

Duffner, Patricia K., Peter C. Burger, Michael E. Cohen, et al.. (1994). Desmoplastic Infantile Gangliogliomas. Neurosurgery. 34(4). 583–589. 56 indexed citations

14.

Lauer, Stephen J., Bruce M. Camitta, Brigid G. Leventhal, et al.. (1993). Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study. Cancer. 71(9). 2854–2861. 14 indexed citations

15.

Crist, W M, J J Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia. 6. 162–165. 28 indexed citations

16.

Shuster, JJ, Andrew J. Carroll, A. Thomas Look, et al.. (1992). Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood. 79(12). 3316–3324. 137 indexed citations

17.

Shuster, Jonathan J., Jeanette Pullen, Jan van Eys, et al.. (1991). Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and down's syndrome. A pediatric oncology group study. Cancer. 67(4). 1057–1063. 46 indexed citations

18.

Eys, Jan van, Jeanette Pullen, David Head, et al.. (1986). The French—American—British (FAB) classification of leukemia. The pediatric oncology group experience with lymphocytic leukemia. Cancer. 57(5). 1046–1051. 30 indexed citations

19.

Sullivan, Margaret P., JM Boyett, Jeanette Pullen, et al.. (1985). Pediatric oncology group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Cancer. 55(2). 323–336. 52 indexed citations

20.

Komp, Diane M., C. Hernández Fernández, John M. Falletta, et al.. (1982). CNS prophylaxis in acute lymphoblastic leukemia. Comparison of two methods a southwest oncology group study. Cancer. 50(6). 1031–1036. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact